Science Friday cover image

Investigating Fraud At The Heart Of Alzheimer’s Research

Science Friday

00:00

Unraveling Alzheimer's Research Misconduct

This chapter investigates the development of the Alzheimer's drug semifilum by Cassava Sciences, uncovering issues of manipulated data and misconduct. It sheds light on the FDA's awareness of these problems, the impact of the amyloid hypothesis on research, and the prevalence of doctored images in scientific studies. The discussion reveals the consequences of confirmation bias and the risk it poses to the integrity of Alzheimer's research.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app